Prosecution Insights
Last updated: July 17, 2026
Application No. 18/376,905

Needle Coke for Graphite Electrode, Needle Coke Manufacturing Method, and Inhibitor

Non-Final OA §102§112
Filed
Oct 05, 2023
Priority
Apr 09, 2021 — JP 2021-066201 +3 more
Examiner
KOPEC, MARK T
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mitsubishi Chemical Corporation
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
926 granted / 1097 resolved
+19.4% vs TC avg
Moderate +13% lift
Without
With
+12.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
25 currently pending
Career history
1111
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
71.5%
+31.5% vs TC avg
§102
15.5%
-24.5% vs TC avg
§112
5.9%
-34.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1097 resolved cases

Office Action

§102 §112
20Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority This application is a CON of PCT/JP2022/017351 (filed 04/08/22), which application claims priority to: JP 2021-066201 (filed 04/09/21), JP 2021-066203 (filed 04/09/21), and to JP 2021-066639 (filed 04/09/21). Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Drawings The Drawings filed 10/05/23 are approved by the examiner. Election/Restrictions Applicant's election with traverse of Group I (claims 1-19) and species (VI) (MB metal of Group 14)in the reply filed on 03/24/26 is acknowledged. The traversal is on the ground(s) that there is no burden to examine the groups in one application. This is not found persuasive because, as stated in the requirement mailed 03/12/26, the searches required for the above distinct groups (and species) are not coextensive. The requirement is still deemed proper and is therefore made FINAL. Information Disclosure Statement The IDS statements filed 10/05/23, 06/05/24, 10/10/24, 05/29/25, 06/18/25, 11/26/25, 02/19/26, 04/07/26 and 04/23/26 have been considered. Initialed copies accompany this action. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 6-9, 16, 18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In each of dependent claims 6 and 16 (and claims dependent thereon), it is unclear if the “further comprising…” metal element and/or metal oxide (Mα) is present as part of the metal or oxide of element (Mβ) recited in in the independent claim(s), or if the metal (Mα) is present as an independent constituent (e.g. a second metal particle or compound). Clarification is required. For examination on the merits, the examiner construes that either alternative is within the scope of these dependent claims. Claim Rejections - 35 USC § 102 and/or 103 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim Construction The examiner construes the preamble limitation “…for graphite electrode production” to recite a statement of intended use. If the body of a claim fully and intrinsically sets forth all of the limitations of the claimed invention, and the preamble merely states, for example, the purpose or intended use of the invention, rather than any distinct definition of any of the claimed invention’s limitations, then the preamble is not considered a limitation and is of no significance to claim construction. Shoes by Firebug LLC v. Stride Rite Children’s Grp., LLC, 962 F.3d 1362, 2020 USPQ2d 10701 (Fed. Cir. 2020). Additionally, applicant’s definition of Group 14 element (i.e. Si, Ge and Sn) at para 0066 of instant PGPUB 2024/0030440 A1 is noted. Lastly, as stated in the above 112 rejection, dependent claims 6 and 16 (and claims dependent thereon) are construed as the metal element and/or metal oxide (Mα) is present as part of the metal or oxide of element (Mβ) recited in in the independent claim(s), or present as an independent constituent (e.g. a second metal particle or compound), with either alternative is within the scope of these dependent claims. Claim(s) 1-19 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by either US 2004/0248724 A1 (Venigalla et al) or TW 201716352A. US 2004/0248724 A1 (Venigalla et al) discloses silicate based sintering aids (Abstract). The reference specifies sintering aids in the form of particles, having the formula BaSiO3 or BaxCa1-xSiO3 (0013; 0026). The disclosed alkaline earth silicate powders, which appear as applicant’s preferred inhibitor compounds (instant PGPUB para 0076; 0164; Table 1 example A6), meet the instant “inhibitor” and intended use preamble limitations and therefore anticipate the above listed claims. TW 201716352A discloses mold flux powder for high aluminum steel. The reference specifies a powder comprising CaO, SiO2, and Al2O3 (Abstract). The disclosed powders, which appear as applicant’s preferred inhibitor compounds (instant PGPUB para 0076; 0098; 0103), meet the instant “inhibitor” and intended use preamble limitations and therefore anticipate the above listed claims. The references are anticipatory. In view of the foregoing, the above claims have failed to patentably distinguish over the applied art. The remaining references listed on forms 892 and 1449 have been reviewed by the examiner and are considered to be cumulative to or less material than the prior art references relied upon in the rejection above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARK T KOPEC whose telephone number is (571)272-1319. The examiner can normally be reached Monday-Friday 9:00a-5:00p EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at 5712707733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MARK KOPEC/Primary Examiner, Art Unit 1762 MK June 5, 2026
Read full office action

Prosecution Timeline

Oct 05, 2023
Application Filed
Jun 09, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679744
METHOD FOR PRODUCING LITHIUM METAL COMPOSITE OXIDE
3y 2m to grant Granted Jul 14, 2026
Patent 12683147
METHOD FOR PRODUCING A GRANULAR CARBON-CARBON COMPOSITE FROM A LIGNIN-CARBON COMPOSITE
2y 1m to grant Granted Jul 14, 2026
Patent 12673894
GRAPHENE OXIDE FINE AGGREGATE IN CEMENT COMPOSITES
2y 8m to grant Granted Jul 07, 2026
Patent 12676300
ELECTRODE MIX FOR SECONDARY BATTERY, ELECTRODE FOR ALL-SOLID-STATE SECONDARY BATTERY, AND ALL-SOLID-STATE SECONDARY BATTERY
1y 8m to grant Granted Jul 07, 2026
Patent 12671086
CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY INCLUDING SAME
3y 3m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
97%
With Interview (+12.9%)
2y 3m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1097 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month